semaglutide
3 Obesity Treatment Secrets That Cut Heavy
Yes, early research indicates GLP-1 receptor agonists can lower alcohol cravings and improve liver markers, but they are not yet FDA-approved for alcohol use disorder (AUD). As obesity rates rise, clinicians are increasingly asking whether the same drugs that trim waistlines might also temper drinking. In 2022, 78 patients participated